Syros Pharmaceuticals Profit Margin 2015-2021 | SYRS
Current and historical gross margin, operating margin and net profit margin for Syros Pharmaceuticals (SYRS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Syros Pharmaceuticals net profit margin as of June 30, 2021 is -442.4%.
|Syros Pharmaceuticals Annual Profit Margins
|Syros Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.